NCT01318187

Brief Summary

STUDY OBJECTIVE: This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol and morphine for the treatment of acute flank pain. METHODS: The investigators conducted a randomized, double-blind, controlled clinical trial comparing single intravenous doses of paracetamol (1 g) and morphine (0.1 mg/kg) for patients presenting to the emergency department (ED) with acute flank pain. Subjects with inadequate pain relief at 30 minutes received rescue fentanyl (0.75 microg/kg).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 18, 2011

Completed
Last Updated

April 1, 2011

Status Verified

January 1, 2011

Enrollment Period

2 months

First QC Date

March 17, 2011

Last Update Submit

March 31, 2011

Conditions

Keywords

renal colicparacetamolmorphineemergency department

Outcome Measures

Primary Outcomes (1)

  • Reduction in visual analogue scale

    The pain of the study subjects was measured after 15th and 30th minutes later after the study drug administered.

    15 minutes interval

Secondary Outcomes (1)

  • Adverse events.

    30th minutes after

Study Arms (2)

Paracetamol

EXPERIMENTAL
Drug: paracetamolDrug: morphine

Morphine

ACTIVE COMPARATOR
Drug: paracetamolDrug: morphine

Interventions

1 gr

Also known as: Perfalgan
MorphineParacetamol

0.1mg/kg intravenous in 100 ml serum physiologic

Also known as: Morphine CHL 0.01 gr
MorphineParacetamol

Eligibility Criteria

Age16 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may not qualify if:

  • known allergy or contraindication to morphine, paracetamol, or any opioid analgesic
  • hemodynamic instability; fever (temperature \> 38°C \[100.4°F\])
  • evidence of peritoneal inflammation
  • documented or suspected pregnancy
  • known or suspected aortic dissection or aneurysm
  • use of any analgesic within 6 hours of ED presentation
  • previous study enrollment Patients with known renal, pulmonary, cardiac, or hepatic failure, as well as those with renal transplantation, were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pamukkale University Hospital Emergency Department

Denizli, 20020, Turkey (Türkiye)

Location

Pamukkale University

Denizli, Turkey (Türkiye)

Location

Related Publications (2)

  • Bektas F, Eken C, Karadeniz O, Goksu E, Cubuk M, Cete Y. Intravenous paracetamol or morphine for the treatment of renal colic: a randomized, placebo-controlled trial. Ann Emerg Med. 2009 Oct;54(4):568-74. doi: 10.1016/j.annemergmed.2009.06.501. Epub 2009 Jul 31.

  • Serinken M, Eken C, Turkcuer I, Elicabuk H, Uyanik E, Schultz CH. Intravenous paracetamol versus morphine for renal colic in the emergency department: a randomised double-blind controlled trial. Emerg Med J. 2012 Nov;29(11):902-5. doi: 10.1136/emermed-2011-200165. Epub 2011 Dec 20.

MeSH Terms

Conditions

UrolithiasisRenal ColicEmergencies

Interventions

AcetaminophenMorphine

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Mustafa Serinken, Proffesor

    Pamukkale University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 17, 2011

First Posted

March 18, 2011

Study Start

January 1, 2011

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

April 1, 2011

Record last verified: 2011-01

Locations